V12 SENTINEL ENGINE · AI MARKET ANALYSIS
Row
L
LXRXAI Stock Diagnostic Report

Lexicon Pharmaceuticals GAAP EPS of -$0.07 misses by $0.02, revenue of $28.9M beats by $24.9M

Lexicon Pharmaceuticals' Q2 2026 EPS fell short of expectations, but revenue significantly exceeded forecasts, resulting in mixed performance.

View Source Article ↗
AI CATALYST SCORE50 / 100Score computed by Sentinel V12
REFERENCE PRICENot measuredReference entry price at analysis time
+
ANALYSIS HISTORY

LXRX Analysis History (Last 30 Days)

Diagnosed AtTickerAI ScoreTier
2026-08-24 12:44:24LXRX85S-ClassView Report →
2026-08-06 11:36:37LXRX50RowView Report →
2026-08-05 17:38:04LXRX50RowView Report →
View Full History for LXRX (Blueprint) →